Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

AOBIADMA

American Oriental Bioengineering, Inc.

Area by area

Overall Quant Score

How does it look overall? (out of 100)

AOBI

28/100

ADMA

77/100

Quality

Is it a profitable, well-run business?

AOBI

2.0/10

ADMA

9.8/10

Growth

Is the company growing?

AOBI

1.5/10

ADMA

5.2/10

Valuation

Is the price reasonable? (higher = cheaper)

AOBI

3.3/10

ADMA

6.7/10

Risk

How risky are the shares? (higher = lower risk)

AOBI

7.5/10

ADMA

4.8/10

Momentum

Is the share price trending up?

AOBI

4.2/10

ADMA

7.7/10

Financial strength

Is the balance sheet healthy?

AOBI

2.3/10

ADMA

8.9/10

The balanced view

Model-generated

American Oriental Bioengineering, Inc.

This company scores below average, with a relatively low-risk profile, although its growth has been slow.

Leads on: risk

Best feature: relatively low risk (Beta (vs. market): 0.20)

Watch out: growth is slow or negative (Revenue growth (FY): -31.8%)

ADMA Biologics, Inc.

This company scores well across most areas, with supportive analyst views and strong profitability.

Leads on: quality, growth, valuation, momentum, financial strength

Best feature: analysts broadly positive (Analyst buy share: 90%)

Watch out: weakest area: risk profile (Largest 1Y drawdown: -63%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.